So-Young Intl (NASDAQ:SY) 주식

So-Young Intl

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenues from information services fees and reservation services fees from medical aesthetic service providers.

News

Penny Stocks

Short Ideas

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

MDIA

SOHU

2024년 4월 8일 기준, 통신 서비스 섹터의 4개 주식이 모멘텀을 상당히 중요하게 생각하는 투자자들에게 실질적 경고를 보내고 있다고 볼 수 있다.RSI는 모멘텀 지표로, 이는 주가가 상승한 날의 주식 강도를 주가가 하락한 날의 주식 강도와 비교한다. 주식 가격의 변화와 비교할 때 주식이 단기간 내에 어떻게 움직일지에 대한 트레이더의 감을 더 잘 줄 수 있다. Benzinga Pro의 보고에 따르면 주로 RSI가 70 이상일 때 주식은 과매수로 간주된다.

2분기에 추락할 수 있는 최상위 기술 및 통신주 4종목

So-Young International Inc. - American Depository Shares

So-Young International Inc

SYRAH RESOURCES LTD by Syrah Resources Ltd.

Syrah Resources Ltd

Sydbank A/S

SAYONA MINING LTD ORD SHS by Sayona Mining Ltd.

Sayona Mining Ltd

Sybleu Inc

SYNTEC BIOFUEL INC by Syntec Biofuel, Inc.

SECURITY BANK CORP by Security Bank Corp.

Security Bank Corp

SYNERGY BRANDS INC by Synergy Brands, Inc.

Stock Yards Bancorp Inc

Synlogic Inc

SANYO CHEMICAL INDUS ORD by Sanyo Chemical Industries, Ltd.

Sanyo Chemical Industries Ltd

Delota Corp

SEYCHELLE ENVRNMNTL TECH by Seychelle Environmental Technologies, Inc.

Seychelle Environmental Technologies Inc

Synchrony Financial

AB Active ETFs, Inc. AB Short Duration High Yield ETF

Synchrony Financial 8.25% PRF PERPETUAL USD 25 - Dep rep 1/40 Ser B

Synchrony Financial Depositary Shares, each Representing a 1/40th Interest in a Share of 5.625% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A

Synchrony Financial Depositary Shares Each Representing a 1/40th Interest in a Share of 8.250% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B

Sylla Gold Corp

Synairgen PLC

Sygnity SA

SYGNIA LTD by SYGNIA LTD.

SKYHARBOUR RES LTD ORD by Skyharbour Resources Ltd.

Skyharbour Resources Ltd

SYMPHONY HOLDINGS ORD by Symphony Holdings, Ltd.

Symphony Holdings Ltd

Synthomer PLC ADR

Synthomer PLC

SYNERGIE WELLNESS PRODS by Synergie Wellness Products, Inc.

Synergie Wellness Products Inc

Symrise AG

Syntax ETF Trust Stratified Total Market II ETF

SYNBIO INTERNATIONAL INC by Synbio International Inc.

Synbio International Inc

Stryker Corp

SOLITON SYSTEMS KK ORD by Soliton Systems

Soliton Systems KK

SKY NETWORK TV by Sky Network Television Ltd.

Sky Network Television Ltd

Cambria Shareholder Yield ETF

Sylo - United States Dollar

Symbotic Inc

SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd

SymBio Pharmaceuticals Ltd

Synapse - United States Dollar

Synaptics Inc

Putnam ETF Trust Putnam BioRevolution ETF

SYNC Network

SYNTHESIS ENERGY SYS INC by Synthesis Energy Systems, Inc.

Synthesis Energy Systems Inc

Synchro Food Co Ltd

SYNEOS HEALTH INC CL A

SYNVISTA THERAPEUTICS INC by Synvista Therapeutics, Inc.

DAY TRADEXCHANGE INC by Day TradeXchange, Inc.

Day TradeXchange Inc

SYMPHONY INTL HLDGS ORD by Symphony International Holdings Ltd.

Symphony International Holdings Ltd

SYENSQO SA U/ADR by Syensqo SA

Silynxcom Ltd

SANYO INDUSTRIES LTD by SANYO INDUSTRIES LTD

Sanyo Industries Ltd

SANYO SPECIAL STEEL ORD by Sanyo Special Steel Co., Ltd.

Sanyo Special Steel Co Ltd

Systena Corp

Sypris Solutions Inc

Scrypt Inc

LIAONING SHUIYUN QINGHE by Liaoning Shuiyun Qinghe Rice Industry Co., Ltd.

Liaoning Shuiyun Qinghe Rice Industry Co Ltd

Syra Health Corp

Spyre Therapeutics Inc

SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals Inc

Syrup - United States Dollar

Sacyr SA

Syscoin

Sysorex Inc

SYLA Technologies Co., Ltd. - American Depositary Shares

SYLA Technologies Co Ltd

Siyata Mobile Inc

ANBC Inc

Syntax ETF Trust Stratified US Total Mkt ETF

SYNOVICS PHARMS INC by Synovics Pharmaceuticals, Inc.

Synovics Pharmaceuticals Inc

SYCAMORE VENTURES INC by Sycamore Ventures, Inc.

Sycamore Ventures Inc

SYNNEX TECH INTL ORD by Synnex Technology International Corp.

SYNNEX TECH INTL GDR 144A by Synnex Technology International Corp.

Synnex Technology International Corp

Synodon Inc

SYNNEX TECH INTL GDR by Synnex Technology International Corp.

Sysco Corp

SYN PROP E TECH SA S/GDR by SYN Prop e Tech SA

SYN Prop E Tech SA

Sylogist Ltd

Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) intravenous (IV) infusion in adult patients with relapsing multiple sclerosis (RMS) compared with the currently approved Ocrevus IV 600 mg dose.
Patients received treatment with Ocrevus high dose or IV 600 mg every 24 weeks for a minimum of 120 weeks.
The <a target="_blank" href="https://www.roche.com/media/releases/med-cor-2025-04-02" rel="noreferrer noopener">trial</a> did not meet its primary endpoint in showing additional benefit in slowing disability progression, as measured by a composite disability over a period of at least 120 weeks of treatment.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44440233/pharmaceutical-firms-say-uk-investment-is-unlikely-unless-payment-levy-is-adressed" rel="noreferrer noopener">Pharmaceutical Firms Say UK Investment Is &#8216;Unlikely&#8217; Unless Payment Levy Is Addressed</a>
The rates of disability progression were low and consistent with rates observed in the previous pivotal studies of Ocrevus IV 600 mg.
In addition, in several predefined analyses on disease activity, Ocrevus IV 600 mg showed clinically meaningful results with the lowest annualized relapse rate (ARR) observed during the double-blind period of a Phase III study in RMS.
The MUSETTE data further support the efficacy and safety profile of the currently approved OCREVUS IV 600 mg dose for RMS.
Ocrevus IV and Ocrevus subcutaneous (SC; marketed as OCREVUS ZUNOVO [ocrelizumab hyaluronidase-ocsq] in the U.S.) are approved for both RMS (including relapsing-remitting multiple sclerosis and active, or relapsing secondary progressive multiple sclerosis, as well as clinically isolated syndrome in the U.S.) and primary progressive multiple sclerosis.
Both Ocrevus IV and subcutaneous are administered every six months. The initial IV dose is given as two 300 mg infusions two weeks apart, with subsequent doses given as single 600 mg infusions.
Ocrevus subcutaneous is given as a single 920 mg subcutaneous injection every six months.
Price Action: RHHBY stock is down 3.89% at $39.48 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44592342/apellis-pharmaceuticals-rare-kidney-disease-drug-under-fda-review-seeks-to-compete-novartis-recently-approved-drug" target="_blank" rel="noreferrer noopener">FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals</a></li>
</ul>
Photo by OleksSH via Shutterstock

Biotech

Large Cap

Health Care

Movers

General

RHHBY

Why Is Pharma Giant Roche Stock Trading Lower On Wednesday?

Legal

Zuckerberg Lobbies Trump To Avoid Meta Antitrust Trial

President Donald Trump is expected to announce sweeping new trade tariffs Wednesday afternoon, calling it "Liberation Day" — a symbolic push to tackle the ballooning U.S. trade deficit <a href="https://www.benzinga.com/topic/tariffs">with major global partners.</a>
Early reports suggest the new reciprocal tariffs could reach as high as 20% on a wide spectrum of imported goods. If confirmed, such measures would raise average U.S. tariffs to levels unseen in decades, stoking uncertainty across global supply chains and financial markets.
Trump is set to reveal more details during his scheduled address from the White House at 4 p.m. Wednesday. 
Markets will be watching closely, not just for the scope and scale of tariffs, but also for potential signals on diplomatic retaliation, corporate lobbying reactions, and the Fed's response.
<h3 class="wp-block-heading">A Historic Deficit Fuels Protectionist Moves</h3>
In 2024, the U.S. imported $3.3 trillion in goods and exported only $2.06 trillion, resulting in a trade deficit exceeding $1.2 trillion, according to data from the International Trade Centre.
January and February 2025 marked the two largest monthly goods deficits ever recorded — $156 billion and $148 billion, respectively, hinting that U.S. businesses may have frontloaded imports in anticipation of higher future costs.
Top trading sources of U.S. imports include Mexico at $510 billion, China at $462 billion, and Canada $422 billion. Imports from Germany totaled $163 billion, predominantly in the automotive sector, while the European Union as a whole supplied $687 billion worth of goods.
Among product categories, automobiles top the list at $219 billion, followed by crude oil and petroleum at $174 billion.
<h3 class="wp-block-heading">Auto Industry In the Crosshairs</h3>
Trump has already enforced a 25% tariff on all foreign car imports. If an additional 20% reciprocal duty is introduced, foreign vehicles could face a combined 45% import tax.
<a href="https://www.benzinga.com/25/04/44610548/trumps-auto-tariffs-could-crush-demand-blow-26-billion-hole-in-industry-profits">Analysts warn</a> this could trigger a severe contraction in U.S. auto sales. Price tags on new vehicles may surge by as much as $15,000, dealing a blow to consumer demand and profit margins of major automakers.
<a href="https://www.benzinga.com/top-stories/25/04/44596034/goldman-warns-trumps-liberation-day-tariffs-could-spike-us-fuel-prices">Goldman Sachs cautioned</a> that if energy products are included in the tariff package, oil and refined product prices including gasoline and diesel could spike sharply, adding to inflationary pressures.
<h3 class="wp-block-heading">Wall Street Reacts: Correction And Caution</h3>
Equity markets are already flashing red. The S&amp;P 500 — as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) — entered correction territory last month, down over 10% from recent highs, and closed its worst quarter since 2022 with a 4.6% loss.
The so-called "Magnificent Seven" — Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — have all posted negative year-to-date returns and are underperforming the broader market.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44598088/trumps-liberation-day-creates-major-uncertainty-for-big-tech-analyst-dan-ives-says">Trump&#8217;s &#8216;Liberation Day&#8217; Creates &#8216;Major Uncertainty&#8217; For Big Tech, Analyst Dan Ives Says</a>
Notably, bullish strategist <a href="https://www.benzinga.com/government/regulations/25/04/44584000/veteran-investor-warns-of-rising-stagflation-risk-as-tariffs-loom-anticipates-squeezed-profit-margins-for-us-businesses">Ed Yardeni</a> revised his S&amp;P 500 earnings forecasts downward and cut his year-end index target, citing risks from trade policy and slowing global demand.
Amid equity outflows, gold has solidified its status as a safe-haven asset, repeatedly hitting record highs and surging 19% year to date as investors seek shelter from mounting uncertainty.
A scenario involving stronger-than-expected retaliatory measures from key trading partners could amplify the market dynamics seen in the first quarter, deepening volatility and risk-off sentiment.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44560485/goldman-sachs-slashes-sp-500-price-outlook-as-tariffs-weaker-growth-hit-earnings">Goldman Sachs Slashes S&amp;P 500 Price Outlook As Tariffs, Weaker Growth Hit Earnings</a>
<h3 class="wp-block-heading">Rising Fears Of Stagflation</h3>
So far, markets have not fully priced in a worst-case economic scenario, one where rising tariffs lead to slower growth coupled with surging prices, also known as stagflation.
Yet, a growing number of economists are increasing their subjective probabilities of a U.S. recession in 2025, especially if retaliatory tariffs hit U.S. exports and <a href="https://www.benzinga.com/25/03/44537936/consumer-inflation-expectations-skyrocket-in-march-hit-highest-levels-in-32-years">consumer sentiment deteriorates.</a>
This week, <a href="https://www.benzinga.com/25/04/44608617/jp-morgan-hikes-us-recession-odds-to-40-tariffs-create-a-dilemma-for-the-fed">JPMorgan raised U.S. probability odds </a>to 40%, up from 30% previously.
Uncertainty also clouds the Federal Reserve's path forward. Although markets currently expect three 25-basis-point rate cuts by the end of 2025, rising inflation risks from new tariffs could tie the Fed's hands.
The central bank may find itself squeezed between the need to support slowing growth and the imperative to fight resurgent price pressures, a policy dilemma reminiscent of the 1970s.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/management/25/04/44597023/trumps-tariffs-could-spark-reshoring-boom-for-these-4-us-stocks">Trump&#8217;s Tariffs Could Spark Reshoring Boom For These 4 US Stocks</a></li>
</ul>
President Trump delivers a live address on tariffs from the White House at 4 p.m. ET.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: Trump Speaks Live From The White House on Liberation Day &#x7C; April 2nd, 2025" width="500" height="281" src="https://www.youtube.com/embed/wgmKYg-zK9o?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Photo: Shutterstock

Analyst Color

Government

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Federal Reserve

Analyst Ratings

Tech

ETFs

AAPL

AMZN

GOOG

GOOGL

MSFT

NVDA

TSLA

Trump's 'Liberation Day' Tariff Reveal Set For 4PM: What's At Stake

BioMarin Pharmaceutical Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) released topline data from the Phase 3 PEGASUS trial evaluating Palynziq&nbsp;(pegvaliase-pqpz) compared to diet alone in 55 adolescents aged <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">12-17 with phenylketonuria (PKU)</a>.
PKU is&nbsp;a rare, inherited metabolic disorder that prevents the body from breaking down the amino acid phenylalanine. Untreated phenylketonuria can lead to brain damage, intellectual disabilities, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44606179/biomarin-announces-positive-pivotal-data-for-palynziq-pegvaliase-pqpz-in-adolescents-with-phenylke" rel="noreferrer noopener">behavioral symptoms or seizures</a>.
The primary endpoints are the changes in blood Phe concentration and characterization of the safety profile in adolescents. Secondary endpoints include changes in total dietary protein intake and pharmacokinetics.&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/02/43849658/why-is-biomarin-stock-trading-higher-on-thursday" rel="noreferrer noopener">Why Is BioMarin Stock Trading Higher On Thursday?</a>
The study met its primary efficacy endpoint, demonstrating a statistically significant lowering in blood Phe levels in adolescents aged 12-17 with phenylketonuria (PKU) compared to diet alone.
Safety results were consistent with the known profile of the medicine.
Palynziq is the first and only enzyme therapy approved to treat adults with PKU.
Detailed results from the PEGASUS study will be presented at an upcoming medical meeting and submitted to global health authorities later this year to request a label expansion for Palynziq to include adolescents.
Palynziq substitutes the deficient phenylalanine hydroxylase (PAH) enzyme in PKU with a PEGylated version of the enzyme phenylalanine ammonia lyase to break down Phe.&nbsp;Palynziq is administered using a dosing regimen designed to facilitate tolerability.
Palynziq is approved to reduce blood Phe concentrations for adults in the U.S., for people 16 and older in the EU,&nbsp;Canada, and&nbsp;Brazil, and for people 15 and older in&nbsp;Japan&nbsp;with PKU who have uncontrolled blood Phe concentrations greater than 600 micromol/L on existing management.
Price Action: BMRN stock is up 0.29% at $68.14 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44592537/wr-berkley-gets-downgraded-to-neutral-analyst-sees-limited-upside-despite-strong-fundamentals" target="_blank" rel="noreferrer noopener">W.R. Berkley Nears Historical Price-To-Book High, Analyst Downgrades Stock On Overvaluation Concerns</a></li>
</ul>

BMRN

BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients

J.P. Morgan analyst Zach Parham reiterated a <a target="_blank" href="https://www.benzinga.com/quote/SM/analyst-ratings" rel="noreferrer noopener">Neutral rating</a> on Wednesday on the shares of SM Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) with a price forecast of $41.00.
Following its January 1 operational takeover, SM continues to integrate its recently acquired Uinta assets. The company has reported no significant impact from prior rail delays or refinery downtime that affected Uinta&#8217;s fourth-quarter performance.
For the first-quarter, oil volumes are expected to slightly exceed the midpoint of SM&#8217;s guidance, with estimates at 103.0 MBo/d, closely aligning with consensus expectations of 103.1 MBo/d, said the analyst.
SM anticipates delivering 45 net Turn-In-Lines (TILs) in first-quarter, which represents 30% of its full-year target of 150 net TILs.
These TILs are weighted toward the later part of the quarter, indicating a greater impact on second-quarter production.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44608286/why-ev-maker-rivian-automotives-stock-is-plunging-today" rel="noreferrer noopener">Why Is EV Maker Rivian Automotive Stock Plunging Today?</a>
As a result, second-quarter oil volumes are projected to rise by 6% quarter-over-quarter to 106.9 MBo/d, aligning with the company&#8217;s full-year 2025 production goal of approximately 107 MBo/d.
With updated commodity prices factored in, SM&#8217;s first-quarter cash flow per share (CFPS) is estimated at $4.37, slightly ahead of the consensus estimate of $4.28.
EBITDA is also projected at $570 million, surpassing the consensus of $559 million. Capital expenditures for the quarter are expected to total $430 million, falling within the company&#8217;s guidance, while free cash flow (FCF) is estimated at $72 million.
Although SM&#8217;s stock buyback program remains in place, no repurchases are expected for first-quarter, with activity likely resuming in the second half of 2025 once leverage approaches 1x.
For the full year, the company projects 107.7 MBo/d of oil production, supported by $1.31 billion in capital spending, resulting in $740 million of free cash flow and a 22% FCF yield, noted the analyst.
In October 2024, SM completed its $2.0 billion all-cash acquisition of XCL Resources, expanding into the Uinta Basin and establishing a third core operational area.
Due to the cash-financed deal, the company is prioritizing debt reduction over share buybacks, aiming to bring leverage below 1x by mid-2025. As a result, SM&#8217;s cash return yield currently lags behind the peer median, the analyst opined.
Price Action: SM shares traded higher by 2.55% at $30.53 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/04/44606109/whats-going-on-with-powersports-retailer-rumbleon-stock-today" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Powersports Retailer RumbleOn Stock Today?</a></li>
</ul>
Photo via Shutterstock.

Equities

Price Target

Reiteration

SM Energy's Near-Term Focus Centers On Debt Reduction Over Stock Buybacks: Analyst

Macro uncertainty has delayed the timeline for an IPO comeback, but there remains substantial pent-up supply for equity issuance.
That&#8217;s according to BofA Securities analyst Craig Siegenthaler, who <a href="https://www.benzinga.com/topic/exchanges" target="_blank" rel="noreferrer noopener">maintained all of his</a> ratings and continues to look for a reopening in the second half of 2025. 
This will restart Nasdaq, Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) strategic flywheel across listings, trading, and corporate services, he says.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/03/44190371/nasdaq-plans-24-hour-trading-to-tap-global-investor-demand" target="_blank" rel="noreferrer noopener">Nasdaq Plans 24-Hour Trading To Tap Global Investor Demand</a>
Siegenthaler continued to forecast the highest 12-month upside for: 
<ul>
<li>Tradeweb Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>); Buy rating, price target $212 from $197.</li>
<li>BGC Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>); Buy rating, price target $15 from $16.</li>
<li>Nasdaq; Buy rating, price target $105 from $103.</li>
<li>Cboe Global Markets, Inc (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>); Buy rating, price target $260 from $251.</li>
</ul>
There is a significant runway left in the electronification of fixed-income markets at Tradeweb Markets, and given their considerable rates business, the analyst noted that Tradeweb Markets will capitalize on the political uncertainty in Washington.
Siegenthaler will look for BGC Group to launch Treasury futures within days and expect their share of the $2 billion revenue per year interest rate futures market to continue accelerating, surpassing 10% in 2027.
The increasingly uncertain macroeconomic and geopolitical backdrop produced ideal conditions for trading across asset classes. 
Accordingly, Siegenthaler raised EPS for his entire market structure coverage. While the analyst expects some downward normalization in volumes into the second half of 2025 (in parallel with a pickup in IPOs), ongoing geopolitical uncertainty will remain an important trading catalyst.
Given his view of second-half normalizations, we are less bullish on Exchange stocks (which outperformed) than the Alts and Brokers.
With market structure stocks up 8% on average in the first quarter of 2025, Nasdaq and Virtu Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) — Buy rating, price target $48 from $56 — have lagged the group.
Nevertheless, the analyst forecasted over 10% first-quarter 2025 EPS beats for both stocks.
Both companies have benefitted from the surge in equity volume in the first quarter of 2025.
Assets under management linked to the Nasdaq-100 have faced beta headwinds related to the choppy equity markets year-to-date. One-third of their indexing revenue is derived from Nasdaq-100 futures, which posted their strongest growth quarter in years (up 38% sequentially) and are seeing strong adoption at the online brokers. In addition, the annual listing price hike (estimated 5%) should more than offset any delisting headwinds. 
Meanwhile, Virtu Financial should also see solid results across its organic initiatives, with industry volumes in options, ETFs, and fixed income higher sequentially.
MarketAxess Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) — Underperform rating, price target $191 from $189 — rallied 12% in March. 
Investors embedded an industrywide mix shift into A2A RFQ, where they are dominant. Siegenthaler noted that portfolio trading (PT) and D2D trading have also logged impressive volumes month-to-date, up 18% and 11% month-on-month (versus +9% for TRACE).
Tradeweb Markets remains dominant in both of these market segments. Accordingly, the analyst does not expect MarketAxess Holdings to post higher market share gains than Tradeweb Markets in March. Meanwhile, Intercontinental Exchange Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) — Buy rating, price target $230 from $237 — will likely experience near-term cyclical headwinds in its mortgage and listing business.
Cboe Global Markets, Inc (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) — Buy rating, price target $260 from $251 — and Tradeweb Markets could see a sequentially adverse product mix shift, given a lower contribution from SPX and muni bonds. 
Futures and index options usage CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) — Underperform rating, price target $219 from $200 — and Cboe Global Markets on Robinhood is ramping nicely. La Nina has been a helpful catalyst for commodity futures. The Mr. Cooper and Rocket Mortgage deal will cost Intercontinental Exchange approximately 410 bps of servicing share and 130 bps of origination share, which the analyst noted amounts to a $72 million headwind.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44608574/chip-giants-arm-qualcomm-target-alphawave-to-capture-ai-success-like-broadcom" target="_blank" rel="noreferrer noopener">Chip Giants Arm, Qualcomm Target Alphawave To Capture AI Success Like Broadcom</a></li>
</ul>
Image: Shutterstock

IPOs

CBOE

MKTX

NDAQ

VIRT

Tradeweb, Nasdaq, Virtu, ICE, BGC Group, Cboe Set To Benefit From IPO Comeback: Analyst

Innovation Beverage Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBG#NASDAQ">IBG</a>) stock is soaring on Wednesday after the company announced a distribution deal <a href="https://www.benzinga.com/pressreleases/25/04/ac44603395/innovation-beverage-group-expands-u-s-distribution-of-its-award-winning-bitters-through-one-of-th">with Republic National Distribution Company (RNDC)</a>.
What To Know: ​The distribution deal will result in the company&#8217;s Australian Bitters and BITTERTALES brands being distributed by RNDC across six states, including California, Oregon, Washington, Hawaii, Arizona and Michigan.
RNDC is one of the U.S.&#8217;s leading wholesale beverage alcohol distributors specializing in wine and spirits.
&#8220;We are very pleased to partner with RNDC, one of the top distributors in the U.S. in our category. Their distribution reach is vast and their product expertise and executional excellence are ideal to promote the expansion of our award-winning bitters brands in the U.S.,&#8221; said IBG&#8217;s Chairman and Interim CEO Sahil Beri.
&#8220;Having recently achieved&nbsp;45%&nbsp;market share in cocktail bitters in Australia, we are eager to gain similar momentum in the U.S.&#8221;
Innovation Beverage Group shares are moving on higher-than-normal session volume of approximately 204 million shares. The company&#8217;s average session volume over the past 100 days is 310,872, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Related Link: <a href="https://www.benzinga.com/insights/options/25/04/44612990/amazon-com-options-trading-a-deep-dive-into-market-sentiment">Amazon.com Options Trading: A Deep Dive into Market Sentiment</a>
IBG Price Action: At the time of writing, Innovation Beverage shares were up 135.4% at $1.15, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

What's Going On With Innovation Beverage Shares Wednesday?

7 analysts have expressed a variety of opinions on First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $27.57, along with a high estimate of $33.00 and a low estimate of $25.00. A 4.93% drop is evident in the current average compared to the previous average price target of $29.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1743620484_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of First Busey by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Tamayo</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Jeff Rulis</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Jeff Rulis</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Damon Delmonte</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$33.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Andrew Liesch</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to First Busey. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of First Busey compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into First Busey's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BUSE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on First Busey analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know First Busey Better</h2>
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
<h3>Unraveling the Financial Story of First Busey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, First Busey showcased positive performance, achieving a revenue growth rate of 7.88% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: First Busey's net margin excels beyond industry benchmarks, reaching 24.24%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): First Busey's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.02%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): First Busey's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial performance.
Debt Management: First Busey's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.23.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BUSE

The Analyst Verdict: First Busey In The Eyes Of 7 Experts

In the preceding three months, 8 analysts have released ratings for Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $193.25, a high estimate of $230.00, and a low estimate of $178.00. This upward trend is apparent, with the current average reflecting a 0.45% increase from the previous average price target of $192.38.
<img src="https://www.benzinga.com/files/images/story/2025/1743620473_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Intercontinental Exchange among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$230.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$189.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$186.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Alex Kramm</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$189.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$178.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$179.00</td>
<td>$187.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Intercontinental Exchange. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Intercontinental Exchange compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Intercontinental Exchange's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Intercontinental Exchange's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ICE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Intercontinental Exchange analyst ratings.</a>
<h2>Unveiling the Story Behind Intercontinental Exchange</h2>
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).
<h3>Unraveling the Financial Story of Intercontinental Exchange</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Intercontinental Exchange's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 13.65%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Intercontinental Exchange's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 23.04%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Intercontinental Exchange's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.54%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Intercontinental Exchange's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.51%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.75.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Intercontinental Exchange Stands With Analysts

Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Old National and provided 12-month price targets. The average target is $27.25, accompanied by a high estimate of $29.00 and a low estimate of $26.00. This current average reflects an increase of 0.93% from the previous average price target of $27.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1743620465_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Old National's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Long</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$27.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>David Long</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$27.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Old National. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Old National compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Old National's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Old National's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ONB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Old National analyst ratings.</a>
<h2>All You Need to Know About Old National</h2>
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
<h3>Unraveling the Financial Story of Old National</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Old National's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.48% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Old National's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 30.58%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Old National's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.45%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Old National's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.28%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Old National's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.84, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Old National In The Eyes Of 4 Experts

In the last three months, 4 analysts have published ratings on Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $4.12, a high estimate of $4.50, and a low estimate of $4.00. This current average has decreased by 10.82% from the previous average price target of $4.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1743620451_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Marqeta. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$4.00</td>
<td>$4.50</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$4.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Marqeta. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Marqeta compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Marqeta's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Marqeta's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MQ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Marqeta analyst ratings.</a>
<h2>Get to Know Marqeta Better</h2>
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
<h3>A Deep Dive into Marqeta's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Marqeta's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 14.28%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Marqeta's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -19.97%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Marqeta's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.49%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Marqeta's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.87%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.01, Marqeta adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Marqeta Through 4 Analysts

10 analysts have shared their evaluations of Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Atlas Energy Solutions and provided 12-month price targets. The average target is $24.65, accompanied by a high estimate of $29.00 and a low estimate of $19.00. This current average represents a 0.72% decrease from the previous average price target of $24.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1743620439_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive Atlas Energy Solutions is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Derek Podhaizer</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$22.00</td>
<td>-</td>
</tr>
<tr>
<td>Derek Podhaizer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Kurt Hallead</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Derek Podhaizer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$23.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Kurt Hallead</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$28.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Atlas Energy Solutions. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Atlas Energy Solutions compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Atlas Energy Solutions's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AESI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Atlas Energy Solutions analyst ratings.</a>
<h2>Delving into Atlas Energy Solutions's Background</h2>
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the most active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
<h3>Atlas Energy Solutions's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Atlas Energy Solutions's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 92.25% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Atlas Energy Solutions's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 5.31%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Atlas Energy Solutions's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.38%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.73%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.51.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AESI

Assessing Atlas Energy Solutions: Insights From 10 Financial Analysts

Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares have fallen close to 30% over the past three months amid CEO Elon Musk&#8216;s political involvement with President Donald Trump.
What To Know: Tesla&#8217;s stock started off the year valued at close to $400, but the stock has faced heavy selling pressure. At the start of the year, Musk took on his role as head of the Department of Government Efficiency (DOGE).
DOGE has cut thousands of jobs since its start, aligning with broader efforts to reduce the size of the federal government. The agency has cut more than 121 contracts, valued at <a href="https://www.newsweek.com/doge-cuts-update-today-contracts-cancelled-2052525">over $350 million</a> since it&#8217;s inception.
Besides impacting the stock price, Musk&#8217;s role in the department may have also resulted in a rise of incidents of vandalism at Tesla properties across the nation. There have been multiple reports of throwing Molotov cocktails, damaging vehicles and occurrences of arson, per Reuters.
The company's sales have declined since the quarter began, with vehicle production reported at 362,615, down from 433,371 a year ago. Deliveries fell to 336,681 from 386,810 in the same period last year.
The stock is now rising slightly on Wednesday after Trump told affiliates that Musk will soon step down from his role as the <a href="https://www.politico.com/news/magazine/2025/04/02/trump-musk-leaving-political-liability-00265784">head of DOGE</a>. While Trump remains pleased with the department and Musk&#8217;s performance, both men have decided that its time for Musk to focus on his business.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44610530/strategic-bitcoin-embrace-by-us-could-trigger-global-crypto-policy-shift-says-grayscale">Strategic Bitcoin Embrace By US Could Trigger Global Crypto Policy Shift, Says Grayscale</a>
TSLA Price Action: At the time of publication, Tesla stock is trading 4.60% higher at $280.62, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: via Shutterstock

Tesla Shares Plunge as Musk's Political Ties Stir Controversy

Hims &amp; Hers Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) short percent of float has risen 5.58% since its last report. The company recently reported that it has 54.73 million shares sold short, which is 28.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Hims &amp; Hers Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743620428_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Hims &amp; Hers Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Hims &amp; Hers Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Hims &amp; Hers Health's peer group average for short interest as a percentage of float is 8.79%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Hims & Hers Health, Inc. Class A Common Stock

HIMS

What's Driving the Market Sentiment Around Hims & Hers Health?

In the current market session, Automatic Data Processing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) share price is at $307.29, after a 0.24% spike. Moreover, over the past month, the stock fell by 1.37%, but in the past year, increased by 26.78%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1743620425_0.png" alt="Past Year Chart" />

<h3>A Look at Automatic Data Processing P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 61.38 in the Professional Services industry, Automatic Data Processing Inc. has a lower P/E ratio of 31.96. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743620425_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Automatic Data Processing Inc's Price Over Earnings

Goldman Sachs Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) short percent of float has fallen 18.59% since its last report. The company recently reported that it has 3.95 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.09 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Goldman Sachs Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743620424_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Goldman Sachs Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Goldman Sachs Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Goldman Sachs Group's peer group average for short interest as a percentage of float is 3.40%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Goldman Sachs Group?

Ratings for eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) were provided by 17 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $68.0, a high estimate of $80.00, and a low estimate of $59.00. Witnessing a positive shift, the current average has risen by 4.71% from the previous average price target of $64.94.
<img src="https://www.benzinga.com/files/images/story/2025/1743620421_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive eBay is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$63.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Daniel Kurnos</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$63.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Ross Sandler</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$64.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Kunal Madhukar</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$72.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Ygal Arounian</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$61.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$59.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Nathan Feather</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Ygal Arounian</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$68.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to eBay. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of eBay compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for eBay's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of eBay's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EBAY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on eBay analyst ratings.</a>
<h2>About eBay</h2>
EBay operates one of the largest e-commerce marketplaces in the world, with $75 billion in 2024 gross merchandise volume rendering the firm a top 10 global e-commerce company. It generates revenue from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2024. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.
<h3>eBay's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, eBay showcased positive performance, achieving a revenue growth rate of 0.66% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: eBay's net margin is impressive, surpassing industry averages. With a net margin of 26.33%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): eBay's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 12.84%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): eBay's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.46%, the company showcases efficient use of assets and strong financial health.
Debt Management: eBay's debt-to-equity ratio surpasses industry norms, standing at 1.52. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EBAY

17 Analysts Have This To Say About eBay

Element Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) short percent of float has risen 71.83% since its last report. The company recently reported that it has 2.72 million shares sold short, which is 1.22% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Element Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743620418_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Element Solutions has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Element Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Element Solutions's peer group average for short interest as a percentage of float is 3.80%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Element Solutions?

J.P. Morgan analyst Anne E. Samuel reiterated the Neutral rating on Premier, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) on Tuesday<a target="_blank" href="https://www.benzinga.com/quote/PINC/analyst-ratings" rel="noreferrer noopener">, with a price forecast of $19.</a>
The analyst notes that Premier&#8217;s stable business is supported by its ownership structure, leading to longer-term contracts typically lasting five to seven years.
Meanwhile, the company&#8217;s growth is closely tied to hospital utilization trends, which has historically led to an expected long-term growth rate of mid-single-digit to high-single-digit percentage increases in both revenue and profit, Samuel adds.
In the short term, though, Premier has experienced weaker performance due to factors like the end of COVID-related stockpiling, rising inflation, and budget constraints faced by hospitals.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44610548/trumps-auto-tariffs-could-crush-demand-blow-26-billion-hole-in-industry-profits" rel="noreferrer noopener">Trump&#8217;s Auto Tariffs Could Crush Demand, Blow $26 Billion Hole In Industry Profits</a>
The analyst highlights several risks that could lead to PINC shares underperforming compared to others.
These risks include a potential slowdown in growth within the Group Purchasing Organization business, due to a weak macroeconomic environment, reduced hospital utilization, and the increasing trend of hospitals forming their own GPOs, as well as heightened competition in the market, the analyst cautions.
Additionally, Samuel adds that the Performance Services business faces significant competition, particularly from larger companies with more capital.
Meanwhile, if hospital utilization trends improve, growth could accelerate, potentially making the analyst&#8217;s current estimates and price target too low, Samuel notes.
Price Action: PINC shares are trading higher by 0.05% to $19.49 at last check Wednesday.
Read now:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44544217/chicken-tax-2-0-bank-of-america-flags-3-million-sales-at-risk-after-auto-tariffs" target="_blank" rel="noreferrer noopener">Chicken Tax 2.0: Bank Of America Flags 3 Million Sales At Risk After Auto Tariffs</a></li>
</ul>
Image via Shutterstock.

PINC

Premier Has Stable Business But Analyst Remains Neutral - Here's Why

<a href="https://www.bloomberg.com/news/articles/2025-04-02/sec-to-restructure-regional-offices-to-streamline-management" title="https://www.bloomberg.com/news/articles/2025-04-02/sec-to-restructure-regional-offices-to-streamline-management">https://www.bloomberg.com/news/articles/2025-04-02/sec-to-restructure-regional-offices-to-streamline-management</a>

Comments

So-Young Intl

뉴스

파트너 / 기고자

벤징가 글로벌